Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > JOHN HOPKINS CONTRACT FAKE NEWS ???
View:
Post by mrmarket1 on Nov 10, 2022 12:17pm

JOHN HOPKINS CONTRACT FAKE NEWS ???

Did they cancel the contract ?????????????!!!!!!!!!!!!!!!!
you don’t need a good memory if there was no intent to explain the contract as promised !!

MEDMIRA AND JOHN HOPKINS IN FINAL  DISCUSSIONS  ?????
Comment by mrmarket1 on Nov 19, 2022 8:14am
No follow up news release on this shows the TRUDEAU STYLE ALOOFNESS MEDMIRA  SUFFERS FROM 
Comment by mrmarket1 on Dec 31, 2022 11:18am
Still not substantiated 
Comment by mrmarket1 on Dec 31, 2022 8:13pm
NOTICE THE QUESTION MARKS 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities